We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Understand Yervoy (ipilimumab) dosage for cancer treatment. Learn about administration, side effects, and when to consult your doctor for personalized care in India.

Facing a cancer diagnosis is an overwhelming experience, and understanding your treatment plan is a vital part of navigating this journey. Yervoy, known scientifically as ipilimumab, is a powerful immunotherapy drug that empowers your own immune system to combat cancer. But how is this complex medication administered? What does the dosage entail? This article aims to demystify the Yervoy dosage, providing clear, practical information for patients and their families in India. We’ll explore the different ways Yervoy is prescribed, depending on the type of cancer, your body weight, and how you respond to treatment. Remember, while this guide offers general insights, your oncologist is the ultimate authority on your personalized treatment plan. They will carefully consider your unique medical history and condition to determine the precise Yervoy dosage that is right for you.
Yervoy belongs to a special class of drugs called monoclonal antibodies. Think of it as a highly targeted tool designed to work with your body’s natural defenses. Specifically, Yervoy is a form of immunotherapy. This means it doesn't directly attack cancer cells like traditional chemotherapy. Instead, it works by blocking a protein called CTLA-4. This protein acts like a brake on your immune system, preventing it from mounting a strong attack against cancer cells. By releasing these brakes, Yervoy essentially unleashes your immune system’s T-cells, enabling them to recognize and destroy cancer cells more effectively. It’s a sophisticated approach that harnesses the power of your own body’s defense mechanisms.
The dosage of Yervoy is never a one-size-fits-all prescription. Your doctor will meticulously calculate it based on several key factors:
The way Yervoy is administered can differ significantly depending on the cancer it's treating. Here’s a breakdown of common dosing scenarios:
For melanoma that cannot be surgically removed or has spread (metastatic melanoma), the dosage is typically 3 mg/kg. This is usually given intravenously (IV) every 3 weeks for up to four doses. Sometimes, Yervoy is combined with another immunotherapy drug called Opdivo. In such cases, after the initial combination therapy, treatment might continue with Opdivo alone for as long as it remains beneficial and safe.
Yervoy also plays a role in preventing melanoma from returning after surgery. For this adjuvant therapy, the initial schedule might be 3 mg/kg every 3 weeks for four doses. This is then followed by a lower dose of 3 mg/kg once every 12 weeks for another four doses.
When used for NSCLC, Yervoy is part of a combination therapy. The dosage is generally 1 mg/kg, administered every 6 weeks. This treatment can continue for up to 2 years, depending on your response and tolerance.
For certain types of colorectal cancer, Yervoy is given at a dosage of 1 mg/kg every 3 weeks, in combination with Opdivo. This initial phase typically lasts for four doses, after which Opdivo may be continued alone for up to 2 years.
In treating a specific type of liver cancer, Yervoy is administered at 3 mg/kg every 3 weeks for up to four doses, alongside Opdivo. Following this, Opdivo might be used as a standalone treatment for an extended period.
Yervoy is used in combination with Opdivo for pleural mesothelioma. The dosage for Yervoy is typically 1 mg/kg every 6 weeks. This combined treatment can continue for up to 2 years, provided it’s effectively managing the cancer.
Yervoy is not a pill you take at home. It is administered as an intravenous (IV) infusion. This means the medication is slowly injected into a vein over a specific period. This is always done in a clinical setting, such as a hospital or a specialized cancer treatment center, by trained healthcare professionals. The infusion process allows the drug to enter your bloodstream directly and begin its work throughout your body. The duration of each infusion can vary, but it is carefully managed by the medical team.
Yervoy is also approved for use in children aged 12 years and older for certain types of cancers, including specific melanomas and colorectal cancers. The dosing principles remain similar, based on weight and the specific condition being treated, and are determined by the pediatric oncologist.
Receiving Yervoy infusions is a significant part of your treatment. Here’s what you might expect:
Because Yervoy works by activating your immune system, it can sometimes cause the immune system to attack healthy tissues and organs. This is known as an immune-related adverse event (irAE). While not everyone experiences these, it’s important to be aware of potential symptoms. These can include:
If you experience any severe or persistent symptoms, contact your doctor immediately. Early detection and management of side effects are critical for a safe and effective treatment course.
Your oncologist is your primary point of contact throughout your Yervoy treatment. You should always consult them if you have any questions or concerns about your dosage, schedule, or any side effects you may be experiencing. Specifically, reach out to your doctor if you notice:
Open communication ensures that your treatment remains safe and effective, allowing you to focus on your recovery.
No, Yervoy is administered as an intravenous (IV) infusion. It cannot be taken by mouth.
The duration of an infusion can vary, but it is typically administered over a period of about 30 to 90 minutes, depending on the specific protocol and your doctor's instructions. Your healthcare team will provide you with specific details.
It's possible. Your doctor may adjust your dosage or treatment schedule based on how you respond to the medication and if you experience any side effects. Regular monitoring is key.
Yervoy can be used alone for certain conditions, but it is often given in combination with other treatments, such as Opdivo, especially for lung, colorectal, and liver cancers.
Yervoy comes in a strength of 5 milligrams (mg) per milliliter (mL) of solution. Your doctor will calculate the total volume needed based on your weight and prescribed dosage (mg/kg).
Confused about whether CBD can get you high? Understand the difference between CBD and THC, their effects on your body, and what to look for in safe, non-intoxicating CBD products.
April 1, 2026
Learn about anticoagulants and antiplatelet drugs, often called blood thinners. Understand how they prevent blood clots, when they're prescribed, their side effects, and essential safety tips for Indian readers.
April 1, 2026

Confused about Plan B and abortion pills? Understand the key differences, how they work, and their effectiveness for informed reproductive health decisions.
April 1, 2026